Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor


Unek I. T. , ÇELTİK A. , Yener S., Yavuzsen T., Alacacioglu A., Cokmert S., ...More

JOURNAL OF BUON, vol.14, no.1, pp.135-138, 2009 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 1
  • Publication Date: 2009
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.135-138

Abstract

Somatostatin and its long-acting analogues are effective in symptom control in patients with functional neuroendocrine tumors; they are also able to control tumor growth. Somatostatin analogues are safe and generally well tolerated. In some cases they may cause serious complications.